Half-life of the maternal IgG1 allotype in infants
Authors:
- 1 March 1993
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 13 (2) , 145-151
Abstract
The residence time of maternal IgG1 in the circulation of infants was measured by monitoring f-allotypic IgG1 or f-positive tetanus toxoid antibody in geneticallyG1m f -negative infants.G1m a -positive maternal tetanus toxoid antibody was similarly monitored in genetically a-negative infants. Blood samples were taken from infants at the age of 1–3 days, ca. 4 months, and ca. 6 months. An exponential decay at the same rate took place from age 1–3 days to 4 months and for the 2 subsequent months. The average concentration of the maternal IgG1 had dropped to ca. 10% of the 1- to 3-day value in 4 months and to ca. 3% in 6 months. The drop was due mainly to clearance but partly also to the weight increase of the child (doubling in 6 months). By correcting for the weight increase, we calculated that ca. 17 and 7% of the original maternal IgG1 was still present at ages 4 and 6 months, respectively. The average half-life of the maternal IgG1 was thus 48.4 days. The concentration of endogenous IgG1 in the cord blood was determined by studying a separate series of mother-newborn pairs. Assuming that cross-reactions of antiallotype reagents had no effect, the highest measured concentration of f-positive IgG1 in infants of f-negative mothers was 10 mg/L, half a percent of adult heterozygote values. Crossreaction may have played a role, however, and the value must be considered the upper limit of the true concentration.Keywords
This publication has 20 references indexed in Scilit:
- The Pharmacokinetics of Total Igg, Igg Subclasses, and Type Specific Antibodies in Immunodeficient PatientsImmunological Investigations, 1991
- Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infantsThe Journal of Pediatrics, 1989
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- Half-Life and Clearance of pH 6.8 and pH 4.25 Immunoglobulin G Intravenous Preparations in Patients with Primary Disorders of Humoral ImmunityClinical Infectious Diseases, 1986
- Alterations in the half-life and clearance of IgG during therapy with intravenous ?-globulin in 16 patients with severe primary humoral immunodeficiencyJournal of Clinical Immunology, 1986
- The bulk of endogenously produced IgG2a is eliminated from the serum of adult C57BL/6 mice with a half‐life of 6–8 daysEuropean Journal of Immunology, 1986
- Metabolic properties of IgG subclasses in manJournal of Clinical Investigation, 1970
- Catabolism of human γG-immunoglobulins of different heavy chain subclassesJournal of Clinical Investigation, 1968
- A Theoretical Model of γ-Globulin CatabolismNature, 1964
- CONCENTRATION OF DIPHTHERIA ANTITOXIN IN CORD BLOOD AND RATE OF LOSS IN BABIESThe Lancet, 1949